Top-Line Data Expected in the Fourth Quarter of 2025 CAMBRIDGE, Mass., July 9, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology ...

GLP-1 RAs are associated with a modestly increased risk for GERD and gallstone disease but not with GI and biliary complications.

ProKidney shares surged 500% on positive Phase 2 CKD results. Read why I remain cautious about PROK stock despite the recent ...

Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic ...

The company’s new range promises to elevate nutritional support for consumers on weight management medications ...

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

"Real Housewives of New Jersey" star Dolores Catania candidly shared her experience with taking weight loss medication and ...

IFT First, the global food science and innovation expo, showcases cutting-edge advancements in food and beverage technology: ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Policy uncertainty and prolonged interest rate stagnation loom over the market like storm clouds and investors are finding ...

The single largest veto affects the Group Insurance Commission, where Healey made a $27.5 million reduction (out of $2.37 ...